Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04480931
Other study ID # 20-257
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 28, 2020
Est. completion date May 1, 2022

Study information

Verified date July 2022
Source Western Kentucky University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this pilot project is to test the feasibility and potential efficacy of the evidence-based mHealth app (BumptUp) for improving physical activity and subsequent health outcomes (i.e. obesity, hypertension, insulin resistance) among pregnant and postpartum women in a rural community. In order to accomplish this goal, feasibility of the intervention protocol will be tested by the assessment of recruitment (how many participants eligible per month), retention (% of women who complete the study protocol), adherence to intervention (% of women who utilize the app), and acceptability (survey and one-on-one exit interviews) during pregnancy and postpartum. Potential efficacy will be determined by examining trends in data on physical activity levels (achieving the goal of 150 minutes per week of physical activity (surveys and accelerometry)) between groups. Other secondary outcomes will also be assessed: weight status, body composition, blood pressure, insulin resistance, fitness levels, mental health, and infant anthropometrics. Clinical hypotheses: 1. The mHealth program will be feasible as evidenced by high rates of enrollment, retention, and adherence, moderate-to-high levels of satisfaction, and low participant burden. 2. The mHealth intervention will show promise towards improving physical activity levels and other secondary outcomes in pregnant and postpartum women in a rural community.


Description:

After contact is established and eligibility confirmed, Participants (N=40) will be enrolled and baseline surveys will be conducted to collect information about lifestyle, mental health, and anxiety levels. Patient data for those participants who have agreed to be in the study and have specifically agreed on the consent form to allow the study team to pull data from their prenatal charts. The data being pulled from charts will include patient weights, vital signs, blood pressures, current complications, blood analytes, and glucose tolerance test results from each prenatal visit. After the baby is born, delivery reports will also be obtained in order to collect information on the delivery outcomes (gender, mode of delivery, complications, time in labor) and baby's anthropometric data (birthweight, birth length, head circumference). Compensation will be in the form of Amazon gift cards (delivered electronically). There will be 4 time points where they take the online assessments. At each time point, they will also be mailed an Actigraph accelerometer to wear for one week. These will be sanitized and mailed or dropped off to avoid any contamination from the study team to participants. When the week is over, the study team will check in with participants and discuss a plan for pick up. They can leave outside for a study team member to pick up (contactless ) or they can mail it back (with provided return envelope). Each participant will still receive a total of $160. They be recruited and consented online around 18-20 weeks. Assessments will occur at 4 timepoints: baseline assessments at 23-25 weeks gestation ($40), phone check at 30 weeks, second assessment/set of surveys at 35-37 weeks ($40), delivery outcomes obtained, 6 week postpartum surveys ($40), and 12 week postpartum surveys ($40). Statistical Analyses: Sample Size Determination: Sample size for this pilot study was determined based on previously performed physical activity interventions among pregnant women. The effect size (0.91) for the main outcome of physical activity was determined from looking at post-intervention physical activity data from Asci et al.83. With this effect size, it was determined using SAS software with a type I error rate of 0.05 that a sample size of 20 per group could detect this difference with 80% power, thus our sample size of 15 per group is justified for a pilot project. Data Analyses: Aim 1: To estimate the success and feasibility of recruitment methods, the number of people who will hear about the study via various methods (e.g. health care providers, health fairs, word-of-mouth) will be estimated. Then, the number of women who completed initial screening, the number of women who meet the eligibility criteria, the number of women who complete each of the assessments, the number of women randomized, and the number of women who adhere to the intervention will be determined. The exit interview data will be analyzed via standard content analyses for qualitative studies as previously described84 (and recently performed by our group). Aim 2: Although the investigators may not detect all between group differences because the investigators are proposing a pilot project, appropriate statistical tests will be performed in order to examine trends, and thus, promise for effect in the larger future trial. Normality of the distribution for each variable will be tested using Kolmogorov-Smirnov tests, and non-normally distributed data will be transformed as needed. The baseline characteristics of the two groups will be compared using t-tests or Chi square tests. The potential effect of the intervention on study outcomes will be explored using repeated measures ANOVAs (group x time). Specifically, physical activity data between groups will be compared from pre-post intervention. All data will be entered in Redcap data management system. Analyses will be conducted using SAS or other statistical software.


Recruitment information / eligibility

Status Completed
Enrollment 38
Est. completion date May 1, 2022
Est. primary completion date December 20, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 44 Years
Eligibility Inclusion Criteria: - 1) Age 18-44 - 2) Confirmed singleton viable pregnancy - 3) English-Speaking (the app is currently only available in English) - 4) Physician release to participate in exercise - 5) Ownership of a smart phone - 6) Plans to deliver at The Medical Center in Bowling Green, KY. Exclusion Criteria: - 1) Multiple gestation pregnancy - 2) Inability to provide voluntary informed consent - 3) Any medical condition (pregnancy-related or not) that would preclude exercise.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
mHealth Intervention Group
Access to the mobile health application with exercise plans and education
Educational Brochure
An evidence-based educational brochure with general information about the benefits of physical activity during pregnancy

Locations

Country Name City State
United States Western Kentucky University Bowling Green Kentucky

Sponsors (2)

Lead Sponsor Collaborator
Western Kentucky University University of Kentucky

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Recruitment feasibility during pregnancy how many participants eligible and successfully recruited per month Pregnancy (23-25 weeks gestation)
Primary Protocol retention % of women who complete the study protocol 12 weeks postpartum
Primary Adherence to intervention % of women who use the app daily Pregnancy (35-37 weeks pregnant)
Primary Adherence to intervention % of women who use the app daily Postpartum (12 weeks after delivery)
Primary Acceptability of Intervention measured via exit interviews Postpartum (12 weeks after delivery)
Primary Physical activity levels Assess the potential efficacy of the intervention by examining physical activity levels through objective actigraph data Pregnancy (23-25 weeks gestation)
Primary Physical activity levels Assess the potential efficacy of the intervention by examining physical activity levels through objective actigraph data Pregnancy (35-37 weeks gestation)
Primary Physical activity levels Assess the potential efficacy of the intervention by examining physical activity levels through objective actigraph data Postpartum (12 weeks)
Primary Physical activity levels Assess the potential efficacy of the intervention by examining physical activity levels through Exercise Vital Sign Survey Postpartum (6 weeks)
Secondary Maternal weight status Body weight (lbs) Pregnancy (23-25 weeks gestation)
Secondary Maternal weight status Body weight (lbs) Pregnancy (35-37 weeks gestation)
Secondary Maternal weight status Body weight (lbs) Postpartum (12 weeks post-delivery)
Secondary Maternal blood pressure Assessed by nurse at clinical visit using standardized clinical equipment Pregnancy (23-25 weeks gestation)
Secondary Maternal blood pressure Assessed by nurse at clinical visit using standardized clinical equipment Pregnancy (35-37 weeks gestation)
Secondary Maternal blood pressure Assessed by nurse at clinical using standardized clinical equipment Postpartum (6 weeks post-delivery)
Secondary Maternal insulin resistance Oral Glucose Tolerance Test Results Pregnancy (24-29 weeks gestation)
Secondary Maternal endothelial dysfunction Assessed with a rapid, non-invasive technique that records endothelium-mediated changes in the peripheral arterial tone signal via a pair of finger probes Pregnancy (35-37 weeks gestation)
Secondary Maternal postpartum depression Edinburgh postpartum depression survey Postpartum (12 weeks post-delivery)
Secondary Maternal mood Profile of Mood Survey Pregnancy (23-25 weeks gestation)
Secondary Maternal mood Profile of Mood Survey Pregnancy (35-37 weeks gestation)
Secondary Maternal mood Profile of Mood Survey Postpartum (6 weeks post-delivery)
Secondary Maternal mood Profile of Mood Survey Postpartum (12 weeks post-delivery)
Secondary Mental Health Center for Epidemiological Studies Depression Survey Pregnancy (23-25 weeks gestation)
Secondary Mental Health Center for Epidemiological Studies Depression Survey Pregnancy (35-37 weeks gestation)
Secondary Mental Health Center for Epidemiological Studies Depression Survey Postpartum (6 weeks post-delivery)
Secondary Mental Health Center for Epidemiological Studies Depression Survey Postpartum (12 weeks post-delivery)
Secondary Infant birthweight Collected at delivery by trained nursing staff At time of delivery
See also
  Status Clinical Trial Phase
Completed NCT03442582 - Afluria Pregnancy Registry
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Enrolling by invitation NCT05415371 - Persistent Poverty Counties Pregnant Women With Medicaid N/A
Completed NCT04548102 - Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman N/A
Completed NCT03218956 - Protein Requirement During Lactation N/A
Completed NCT02191605 - Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy N/A
Completed NCT02223637 - Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
Recruiting NCT06049953 - Maternal And Infant Antipsychotic Study
Completed NCT02577536 - PregSource: Crowdsourcing to Understand Pregnancy
Not yet recruiting NCT06336434 - CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy Phase 1/Phase 2
Not yet recruiting NCT05412238 - Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months N/A
Not yet recruiting NCT04786587 - Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
Not yet recruiting NCT05028387 - Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
Completed NCT02783170 - Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women Phase 4
Completed NCT02683005 - Study of Hepatitis C Treatment During Pregnancy Phase 1
Recruiting NCT02619188 - Nutritional Markers in Normal and Hyperemesis Pregnancies N/A
Recruiting NCT02507180 - Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
Recruiting NCT02564250 - Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women N/A
Completed NCT02408315 - Induction With Misoprostol: Oral Mucosa Versus Vaginal Epithelium (IMPROVE) Phase 3